PM Q1 2026 Earnings EPS Surpasses Estimates by 414 Halozyme Therapeutics Inc HALO Q1 2026 Earnings EPS Surpasses Estimates Despite Flat Revenue Disclosure FRHC Q1 2026 Earnings EPS of 125 Highlights Profitability Amid Sparse Disclosure Primoris Services PRIM Q1 2026 Earnings EPS Misses Estimates Yet Stock Rallies NCTY Q1 2012 Earnings Narrower Loss Beats Estimates as Company Restructures MED Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise